Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Logothetis

Showing results (71-80 of 150) with videos related to

Pageof 15
Sort By:
The Journal of Urology|October 1, 1994
Neoadjuvant cisplatin and interferon-alpha 2B in the treatment and organ preservation of penile carcinomaD Mitropoulos, M A Dimopoulos, A Kiroudi-Voulgari, et al.
Yonsei Medical Journal|May 20, 1999
Clinical characteristics of metachronous bilateral testicular tumors in the chemotherapeutic eraD S Park, D M Prow, R J Amato, et al.
Cancer Treatment Reports|January 1, 1982
Doxorubicin, mitomycin, and 5-FU (DMF) in the treatment of hormone-resistant stage D prostate cancer: a preliminary reportC J Logothetis, A C von Eschenbach, M L Samuels, et al.
British Journal of Cancer|April 3, 1999
Increased transcriptional activity of prostate-specific antigen in the presence of TNP-470, an angiogenesis inhibitorJ Horti, S C Dixon, C J Logothetis, et al.
The Journal of Urology|May 1, 1995
The results of a phase II randomized trial comparing 5-fluorouracil and 5-fluorouracil plus alpha-interferon: observations on the design of clinical trials for androgen-independent prostate cancerD D Daliani, P D Eisenberg, J Weems, et al.
The Journal of Urology|October 1, 1987
Cyclophosphamide and sequential cisplatin for advanced seminoma: long-term followup in 52 patientsC J Logothetis, M L Samuels, S L Ogden, et al.
Cancer|July 10, 2001
Gemcitabine modulation of alkylator therapy: a phase I trial of escalating gemcitabine added to fixed doses of ifosfamide and doxorubicinR E Millikan, W K Plunkett, T L Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
Phase II study of ketoconazole combined with weekly doxorubicin in patients with androgen-independent prostate cancerA Sella, R Kilbourn, R Amato, et al.
The Journal of Urology|November 1, 1991
Combination chemotherapy with methotrexate, bleomycin and cisplatin for advanced squamous cell carcinoma of the male genital tractF H Dexeus, C J Logothetis, A Sella, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1988
Successful treatment of pure endodermal sinus tumors in adult menC D Chong, C J Logothetis, A C von Eschenbach, et al.
Pageof 15

Showing results (71-80 of 150) with videos related to

Sort By:
Pageof 15
The Journal of Urology|October 1, 1994
Neoadjuvant cisplatin and interferon-alpha 2B in the treatment and organ preservation of penile carcinomaD Mitropoulos, M A Dimopoulos, A Kiroudi-Voulgari, et al.
Yonsei Medical Journal|May 20, 1999
Clinical characteristics of metachronous bilateral testicular tumors in the chemotherapeutic eraD S Park, D M Prow, R J Amato, et al.
Cancer Treatment Reports|January 1, 1982
Doxorubicin, mitomycin, and 5-FU (DMF) in the treatment of hormone-resistant stage D prostate cancer: a preliminary reportC J Logothetis, A C von Eschenbach, M L Samuels, et al.
British Journal of Cancer|April 3, 1999
Increased transcriptional activity of prostate-specific antigen in the presence of TNP-470, an angiogenesis inhibitorJ Horti, S C Dixon, C J Logothetis, et al.
The Journal of Urology|May 1, 1995
The results of a phase II randomized trial comparing 5-fluorouracil and 5-fluorouracil plus alpha-interferon: observations on the design of clinical trials for androgen-independent prostate cancerD D Daliani, P D Eisenberg, J Weems, et al.
The Journal of Urology|October 1, 1987
Cyclophosphamide and sequential cisplatin for advanced seminoma: long-term followup in 52 patientsC J Logothetis, M L Samuels, S L Ogden, et al.
Cancer|July 10, 2001
Gemcitabine modulation of alkylator therapy: a phase I trial of escalating gemcitabine added to fixed doses of ifosfamide and doxorubicinR E Millikan, W K Plunkett, T L Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
Phase II study of ketoconazole combined with weekly doxorubicin in patients with androgen-independent prostate cancerA Sella, R Kilbourn, R Amato, et al.
The Journal of Urology|November 1, 1991
Combination chemotherapy with methotrexate, bleomycin and cisplatin for advanced squamous cell carcinoma of the male genital tractF H Dexeus, C J Logothetis, A Sella, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1988
Successful treatment of pure endodermal sinus tumors in adult menC D Chong, C J Logothetis, A C von Eschenbach, et al.
Pageof 15